Consolidated Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7580403

Concept 2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2019-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,767,150,000 JPY
-1,782,376,000 JPY
Interest and dividends received
35,000 JPY
42,000 JPY
Income taxes paid
-2,732,000 JPY
-2,127,000 JPY
Net cash provided by (used in) operating activities
-1,769,848,000 JPY
-1,784,461,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-34,920,000 JPY
-107,282,000 JPY
Proceeds from sale of property, plant and equipment
JPY
495,000 JPY
Net cash provided by (used in) investing activities
-36,211,000 JPY
-106,879,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
2,053,090,000 JPY
8,521,000 JPY
Net increase (decrease) in cash and cash equivalents
247,031,000 JPY
-1,882,820,000 JPY
Cash and cash equivalents
3,265,388,000 JPY
3,018,356,000 JPY
4,901,177,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.